1. Home
  2. AXSM vs GTES Comparison

AXSM vs GTES Comparison

Compare AXSM & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • GTES
  • Stock Information
  • Founded
  • AXSM 2012
  • GTES 1911
  • Country
  • AXSM United States
  • GTES United States
  • Employees
  • AXSM N/A
  • GTES N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • GTES Industrial Machinery/Components
  • Sector
  • AXSM Health Care
  • GTES Industrials
  • Exchange
  • AXSM Nasdaq
  • GTES Nasdaq
  • Market Cap
  • AXSM 5.1B
  • GTES 5.2B
  • IPO Year
  • AXSM 2015
  • GTES 2018
  • Fundamental
  • Price
  • AXSM $100.69
  • GTES $21.97
  • Analyst Decision
  • AXSM Strong Buy
  • GTES Buy
  • Analyst Count
  • AXSM 16
  • GTES 10
  • Target Price
  • AXSM $170.50
  • GTES $23.60
  • AVG Volume (30 Days)
  • AXSM 627.1K
  • GTES 1.3M
  • Earning Date
  • AXSM 08-04-2025
  • GTES 07-30-2025
  • Dividend Yield
  • AXSM N/A
  • GTES N/A
  • EPS Growth
  • AXSM N/A
  • GTES N/A
  • EPS
  • AXSM N/A
  • GTES 0.83
  • Revenue
  • AXSM $432,157,000.00
  • GTES $3,393,200,000.00
  • Revenue This Year
  • AXSM $62.84
  • GTES $1.40
  • Revenue Next Year
  • AXSM $60.02
  • GTES $4.48
  • P/E Ratio
  • AXSM N/A
  • GTES $26.44
  • Revenue Growth
  • AXSM 72.16
  • GTES N/A
  • 52 Week Low
  • AXSM $72.02
  • GTES $14.70
  • 52 Week High
  • AXSM $139.13
  • GTES $23.85
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 37.30
  • GTES 58.43
  • Support Level
  • AXSM $99.39
  • GTES $21.67
  • Resistance Level
  • AXSM $112.98
  • GTES $22.35
  • Average True Range (ATR)
  • AXSM 3.33
  • GTES 0.43
  • MACD
  • AXSM -0.76
  • GTES -0.07
  • Stochastic Oscillator
  • AXSM 9.35
  • GTES 76.24

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About GTES Gates Industrial Corporation plc

Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.

Share on Social Networks: